Synaptics (SYNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Edison International (EIX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This ...

Central Garden (CENT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Procept BioRobotics Corporation (NASDAQ:PRCT) is one of the best up and coming stocks to buy according to Wall Street.

Buy IMAX (IMAX) stock: strong network effects, underpenetrated screens, 470+ orders, Netflix Narnia upside. Read here for ...

Stryker builds an ASC ecosystem that drives growth, but margin pressure persists. Click here to read my latest analysis of ...

These four Berkshire Hathaway holdings are safe Buffett stocks and look like total return home runs for 2026 and beyond.

They have also shared their outlook on pharmaceuticals, telecom, healthcare, metals and banking, alongside broader commentary on India’s growth outlook, GDP trajectory and the evolving earnings cycle.

These five high-yield dividend stocks with solid upside potential and Buy ratings make sense for growth and income investors ...